415 related articles for article (PubMed ID: 12634359)
1. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU.
Burkhart MD; Kayman SC; He Y; Pinter A
J Virol; 2003 Apr; 77(7):3993-4003. PubMed ID: 12634359
[TBL] [Abstract][Full Text] [Related]
2. Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor.
Ikeda H; Kato K; Suzuki T; Kitani H; Matsubara Y; Takase-Yoden S; Watanabe R; Kitagawa M; Aizawa S
J Virol; 2000 Feb; 74(4):1815-26. PubMed ID: 10644355
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the C-terminal disulfide-bonded loop of murine leukemia virus SU protein in a postbinding step critical for viral entry.
Burkhart MD; D'Agostino P; Kayman SC; Pinter A
J Virol; 2005 Jun; 79(12):7868-76. PubMed ID: 15919941
[TBL] [Abstract][Full Text] [Related]
4. Effects of subtle changes in the SU protein of ecotropic murine leukemia virus on its brain capillary endothelial cell tropism and interference properties.
Masuda M; Hanson CA; Alvord WG; Hoffman PM; Ruscetti SK; Masuda M
Virology; 1996 Jan; 215(2):142-51. PubMed ID: 8560761
[TBL] [Abstract][Full Text] [Related]
5. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus.
Kim FJ; Seiliez I; Denesvre C; Lavillette D; Cosset FL; Sitbon M
J Biol Chem; 2000 Aug; 275(31):23417-20. PubMed ID: 10851227
[TBL] [Abstract][Full Text] [Related]
6. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
[TBL] [Abstract][Full Text] [Related]
7. The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain.
Wissink EHJ; van Wijk HAR; Kroese MV; Weiland E; Meulenberg JJM; Rottier PJM; van Rijn PA
J Gen Virol; 2003 Jun; 84(Pt 6):1535-1543. PubMed ID: 12771423
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
Kuo CW; Mirsaliotis A; Brighty DW
J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
[TBL] [Abstract][Full Text] [Related]
9. Natural immunity in mice to the envelope glycoprotein of endogenous ecotropic type C viruses: neutralization of virus infectivity.
Ihle JN; Lazar B
J Virol; 1977 Mar; 21(3):974-80. PubMed ID: 191656
[TBL] [Abstract][Full Text] [Related]
10. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
Cairns TM; Shaner MS; Zuo Y; Ponce-de-Leon M; Baribaud I; Eisenberg RJ; Cohen GH; Whitbeck JC
J Virol; 2006 Mar; 80(6):2596-608. PubMed ID: 16501070
[TBL] [Abstract][Full Text] [Related]
13. Characterization of monoclonal antibodies recognizing neurotropic Friend murine leukemia virus.
Ikeda T; Takase-Yoden S; Watanabe R
Virus Res; 1995 Oct; 38(2-3):297-304. PubMed ID: 8578867
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
15. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.
Evans LH; Morrison RP; Malik FG; Portis J; Britt WJ
J Virol; 1990 Dec; 64(12):6176-83. PubMed ID: 1700832
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus.
Chesebro B; Britt W; Evans L; Wehrly K; Nishio J; Cloyd M
Virology; 1983 May; 127(1):134-48. PubMed ID: 6305011
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
Babas T; Le Grand R; Dormont D; Bahraoui E
AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
[TBL] [Abstract][Full Text] [Related]
18. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the N termini of murine leukemia virus envelope proteins.
Lu CW; Roth MJ
J Virol; 2001 May; 75(9):4357-66. PubMed ID: 11287584
[TBL] [Abstract][Full Text] [Related]
20. Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.
Lavillette D; Ruggieri A; Boson B; Maurice M; Cosset FL
J Virol; 2002 Oct; 76(19):9673-85. PubMed ID: 12208946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
